82 results
Page 2 of 5
8-K
EX-99.1
j9c fvmrptl
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
0gcxvrgq
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
2nyuf6ql0f2pfqtiva
14 Aug 20
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
8:30am
DEFA14A
ptycgp 3sxd599zn
29 May 20
Additional proxy soliciting materials
9:30am
8-K
EX-99.1
6jxdu42ijt
11 May 20
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
oflv0xobmm4kbv11l5o
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
ki6asi y6zgb
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
8-K
EX-99.1
0rhvar5d 293vhbrso
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
EX-99.1
t3ko kqsfv6xl
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-99.1
4c64qfjt
4 Nov 19
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
mkq2oxh8qxdu
14 Aug 19
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
12:00am
8-K
fedh05dywllkm8z6
1 Aug 19
Departure of Directors or Certain Officers
9:00am
8-K
EX-99.1
q99lghgb
3 Jun 19
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
8:45am